• Register
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.


Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.


The E3 ubiquitin ligase mind bomb-2 (MIB2) protein controls B-cell CLL/lymphoma 10 (BCL10)-dependent NF-κB activation.

B-cell CLL/lymphoma 10 (BCL10) is crucial for the activation of NF-κB in numerous immune receptor signaling pathways, including the T-cell receptor (TCR) and B-cell receptor signaling pathways. However, the molecular mechanisms that lead to signal transduction from BCL10 to downstream NF-κB effector kinases, such as TAK1 and components of the IKK complex, are not entirely understood. Here we used a proteomic approach and identified the E3 ligase MIB2 as a novel component of the activated BCL10 complex. In vitro translation and pulldown assays suggest direct interaction between BCL10 and MIB2. Overexpression experiments show that MIB2 controls BCL10-mediated activation of NF-κB by promoting autoubiquitination and ubiquitination of IKKγ/NEMO, as well as recruitment and activation of TAK1. Knockdown of MIB2 inhibited BCL10-dependent NF-κB activation. Together, our results identify MIB2 as a novel component of the activated BCL10 signaling complex and a missing link in the BCL10-dependent NF-κB signaling pathway.

Pubmed ID: 21896478


  • Stempin CC
  • Chi L
  • Giraldo-Vela JP
  • High AA
  • Häcker H
  • Redecke V


The Journal of biological chemistry

Publication Data

October 28, 2011

Associated Grants

  • Agency: NIAID NIH HHS, Id: AI083443

Mesh Terms

  • Adaptor Proteins, Signal Transducing
  • Animals
  • HEK293 Cells
  • Humans
  • I-kappa B Kinase
  • Intracellular Signaling Peptides and Proteins
  • Jurkat Cells
  • MAP Kinase Kinase Kinases
  • Mice
  • NF-kappa B
  • Proteomics
  • Signal Transduction
  • Ubiquitin-Protein Ligases
  • Ubiquitination